secwatch.observer — SEC 8-K summary
======================================

Issuer:     INFINITY PHARMACEUTICALS, INC. (—)
CIK:        0001113148
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001113148-23-000018
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Infinity Pharmaceuticals files Chapter 11; all shares expected to be canceled
-----------------------------------------------------------------------------

- Filed voluntary Chapter 11 petition in Delaware on Sept 29, 2023 (Case No. 23-11640).
- Engaged Sonoran Capital Advisors and SSG Advisors for restructuring and potential asset sale.
- Expects cancellation of all outstanding common stock without any payment or distribution.
- Chair Adelene Perkins resigned from Board on Sept 28, 2023; not due to any disagreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1113148/000111314823000018/0001113148-23-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1113148/000111314823000018/infi-20230928.htm
  HTML page:      https://secwatch.observer/filing/0001113148-23-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer